Jeff Yass’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-87,500
Closed -$243K 14603
2022
Q3
$243K Buy
87,500
+48,300
+123% +$117K ﹤0.01% 10347
2022
Q2
$48K Sell
39,200
-19,200
-33% -$32.2K ﹤0.01% 12004
2022
Q1
$169K Sell
58,400
-73,900
-56% -$314K ﹤0.01% 11446
2021
Q4
$885K Sell
132,300
-8,500
-6% -$82.5K ﹤0.01% 7613
2021
Q3
$1.85M Buy
140,800
+117,600
+507% +$2.5M ﹤0.01% 6000
2021
Q2
$928K Buy
+23,200
New +$916K ﹤0.01% 7969

Jeff Yass's ZY Position: Q4 2022 in Review

Jeff Yass sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 181,957 shares — an estimated $506K sold.

Jeff Yass first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $777K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Jeff Yass reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 181,957 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $506K.
  • Jeff Yass first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Jeff Yass's Zymergen Inc. Common Stock position peaked at $777K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.